April 19, 2026 a 08:38 am
CAH: Analysts Ratings - Cardinal Health, Inc.
Cardinal Health, Inc. operates as a significant player in the healthcare services and products landscape, offering extensive solutions across various medical sectors. The firm's diversified reach and robust industry presence make its stock a focal point among analysts. Given the consistent demand for medical supplies, Cardinal Health remains an integral component of healthcare infrastructure, warranting close observation of its market dynamics.
Historical Stock Grades
| Recommendation Type | Count | Score Bar |
|---|---|---|
| Strong Buy | 2 | |
| Buy | 11 | |
| Hold | 4 | |
| Sell | 0 | |
| Strong Sell | 0 |
Sentiment Development
The analyst sentiment towards Cardinal Health remains generally positive, with predominant 'Buy' recommendations. The past months have shown stability in recommendations, maintaining a balance between 'Buy' and 'Hold'. The trend indicates a cautious optimism, with no 'Sell' sentiments present.
- The total number of recommendations has varied slightly over the months.
- 'Buy' sentiments consistently lead, emphasizing confidence in the stock.
- No significant negative sentiment ('Sell' or 'Strong Sell') has been reported recently, reflecting trust in company performance.
Percentage Trends
The adjustment in analyst ratings over time reveals slight shifts in emphasis, particularly towards 'Buy' recommendations. The percentage of 'Strong Buy' has remained resilient, though a modest increase in 'Hold' sentiments suggests emerging caution.
- Strong Buy: Steady at approximately 9-10% over several months.
- Buy: Dominates with around 50-55%, showing strong analyst backing.
- Hold: Maintains a presence around 20% but suggests a vigilant approach.
- No substantial increase in negative endorsements indicates stable market trust.
Latest Analyst Recommendations
Recent analyst recommendations for Cardinal Health underscore continuity in market perspectives, with most maintaining the current stance. This reinforces the perception of Cardinal Health as a stable investment.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-04-08 | Outperform | Outperform | Evercore ISI Group |
| 2026-02-24 | Overweight | Overweight | Barclays |
| 2026-02-10 | Neutral | Neutral | JP Morgan |
| 2026-02-10 | Overweight | Overweight | Wells Fargo |
| 2026-02-06 | Outperform | Outperform | Mizuho |
Analyst Recommendations with Change of Opinion
Noteworthy upgrades in Cardinal Health indicate a shift in analyst confidence, potentially driven by new financial data or strategic moves by the company. This can be seen in several adjustments from neutral to more favorable ratings.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-01-09 | Buy | Neutral | Citigroup |
| 2025-06-03 | Overweight | Equal Weight | Wells Fargo |
| 2025-02-05 | Buy | Hold | Jefferies |
| 2025-01-08 | Buy | Hold | TD Cowen |
| 2025-01-07 | Outperform | In Line | Evercore ISI Group |
Interpretation
The market sentiment towards Cardinal Health suggests a predominantly optimistic view, with significant 'Buy' and 'Strong Buy' recommendations reflecting confidence in the company's strategic direction. The lack of 'Sell' ratings implies steadfast belief in its market positioning. Nonetheless, a moderate level of 'Hold' recommendations indicates cautious scrutiny by analysts, highlighting the need for consistent performance to sustain momentum.
Conclusion
Cardinal Health, Inc. presents a stable investment with its broad spectrum of services and products positioning it as a vital player in the healthcare industry. The consistency in 'Buy' recommendations underlines the company's resilience and appeal. However, the observable trend towards cautious 'Hold' ratings suggests potential market uncertainties. Analysts remain watchful for substantive operational outcomes that could further solidify investor confidence or trigger cautionary shifts. Investors should weigh these dynamics when considering an investment in Cardinal Health.